Pioneering innovations reached by the Emirati scientist and researcher in the field of bioengineering, Dr. Fatima Al Mulla, and consultant orthopedic surgeon, Dr. Ali Al Balushi, contributed to their winning the UAE Pride Medal, in the categories of the Mohammed bin Rashid Government Excellence Award, as the first is working on developing a vaccine with technology. DNA plasma, while Al Balushi introduced robotic joint surgery to the Middle East, and was even able to modernize his systems and programming.
In detail, the Emirati researcher at UCL University, Dr. Fatima Muhammad Al Mulla, revealed that her family was not aware of her winning the Emirates Pride Medal, as she received a call from the administration of the Mohammed bin Rashid Award for Government Excellence, hours before she was honored with the best award in her life, according to She told “Emirates Today”.
Al Mulla added that she is currently working on developing a “plasmid” vaccine with DNA technology, which was used in the “Pfizer” and “AstraZeneca” vaccines, in light of her work in a research company specialized in developing vaccines, and she also teaches master’s students at the University of London. She expressed her hope to contribute to the realization of her country’s vision for the future, and its quest to be a leader in the manufacture of vaccines and medicines, noting that the “Covid-19” pandemic confirmed the UAE’s ability to occupy an advanced position in these industries in the future.
For his part, consultant orthopedic and joint surgery, Dr. Ali Al Balushi, winner of the UAE Pride Medal, said that he feels very proud to appreciate his efforts and colleagues in this field, noting that he was the first to bring the robot to the UAE and the Middle East for use in joint surgeries, in 2018, And he conducted more than 1,000 operations, and developed its programming and systems with the work team, which contributed to bringing the latest robot of its kind in 2021, after its use in America directly, and before it reached Europe or South Korea and other countries, which represents a personal achievement for him and his country. Al Balushi stressed that the future is heading towards this type of surgery, as it reduces the percentage of surgical errors from 20% to less than half a percent, improves the patient’s recovery chances, and eliminates the need for secondary operations to treat collateral damage, as it will reduce the value of manufacturing devices that are used in this The type of surgery, stressing that the center is currently a destination for training surgeons from different countries of the world to perform robotic operations.